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Summary
Functional imaging signals arise from metabolic and
hemodynamic activity, but how theseprocessesare re-
lated to thesynaptic andelectrical activityofneurons is
not well understood. To provide insight into this issue,
we used in vivo imaging and simultaneous local phar-
macology to study how sensory-evoked neural activity
leads to intrinsic optical signals (IOS) in the well-de-
fined circuitry of the olfactory glomerulus. Odor-
evoked IOSwere tightlycoupled to releaseofglutamate
and were strongly modulated by activation of presyn-
aptic dopamine and GABA-B receptors. Surprisingly,
IOS were independent of postsynaptic transmission
through ionotropic or metabotropic glutamate recep-
tors, but instead were inhibited when uptake by astro-
cytic glutamate transporters was blocked. These data
suggest that presynaptic glutamate release anduptake
by astrocytes form a critical pathway through which
neural activity is linked to metabolic processing and
hence to functional imaging signals.
Introduction
Functional imaging methods provide a readout of dis-
tributed patterns of brain activity that cannot be readily
obtained with electrophysiological recordings. Intrinsic
optical signals (IOS) have provided unique insight into
the functional architecture of brain circuitry, notably
those of the visual system (Bonhoeffer and Grinvald,
1991; 1996) and the olfactory bulb (Rubin and Katz
1999; Uchida et al., 2000; Meister and Bonhoeffer,
2001; Wachowiak and Cohen, 2003; Uchida and Mainen
2003). However, despite their utility, the relationship of
functional imaging signals to conventional neural activ-
ity remains poorly understood (Bonvento et al., 2002;
Heeger and Ress, 2002; Raichle, 2003). Functional sig-
nals are generally derived from metabolic and vascular
responses to neural activity. In particular, changes in
blood oxygenation and flow produce both IOS and
fMRI signals (Ogawa et al., 1990; Bonhoeffer and Grin-
vald, 1996), while light-scattering changes related to
metabolic activity also contribute to IOS (Aitken et al.,
1999). Therefore, understanding how metabolism is
coupled to electrical and synaptic activity would provide
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Cambridge, Massachusetts 02138.important insight into the interpretation of functional im-
aging signals (Shulman and Rothman, 1998; Magistretti
et al., 1999; Raichle and Mintun, 2006).
Excitatory postsynaptic potentials and action poten-
tials are predicted to be the most energetically costly
components of neural signaling (Attwell and Laughlin,
2001), but energy supply and consumption in the brain
are not passively coupled; rather, they are linked by ac-
tive and dynamic processes (Attwell and Iadecola,
2002). Indeed, spiking activity can be completely de-
coupled from cerebral blood flow changes (Mathiesen
et al., 1998; Caesar et al., 2003; Thomsen et al., 2004).
The processes by which neurons signal their energy
needs are not well understood, yet much evidence sug-
gests that astrocytes are essential participants in the
regulation of metabolic (Pellerin and Magistretti, 1994;
Cholet et al., 2001; Voutsinos-Porche et al., 2003) and
vascular responses (Zonta et al., 2003; Mulligan and
MacVicar, 2004; Takano et al., 2005). Thus, it is possible
that functional imaging signals depend more directly on
activity in astrocytes than on activity in neurons. How-
ever, the involvement of astrocytes in functional imaging
signals has never been demonstrated directly.
In this study, we used in vivo pharmacology, electro-
physiology, and imaging to characterize the signaling
pathways by which neural activity is linked to IOS in
the olfactory bulb. Olfactory bulb IOS originate predom-
inantly from the olfactory glomeruli (Meister and Bon-
hoeffer, 2001; Belluscio and Katz, 2001), spherical re-
gions of neuropil with a relatively simple intrinsic
circuitry that is advantageous for study of signaling
pathways in vivo. Each glomerulus receives a unitary
and homogeneous afferent input directly from a single
type of primary sensory neuron (Wachowiak et al.,
2004). Sensory afferents release glutamate onto local in-
terneurons (juxtaglomerular cells; JGCs) and principal
neurons (mitral and tufted cells; M/TCs), which form re-
ciprocal synapses with one another and with presynap-
tic afferents (Shepherd and Greer, 1998).
We used local pharmacological manipulations to in-
terfere with the pathway from odor-evoked action po-
tentials in olfactory nerve inputs to the induction of IOS
in the glomerulus. In this way, by probing the relative im-
portance of presynaptic (release and astrocytic uptake)
versus postsynaptic (activation of glutamate receptors)
mechanisms in the genesis of the IOS, we could dissect
the mechanisms of a functional imaging signal in vivo.
We report two major results. First, the sensory-evoked
IOS track presynaptic activity and are tightly regulated
by dopamine (DA) and g-amino-n-butyric acid (GABA)-
B receptors. Second, the IOS are not dependent on
postsynaptic glutamate receptor activation but are
linked to glutamate release and uptake by astrocytic
glutamate transporters.
Results
Activity Dependence of IOS Components
We imaged IOS in the dorsal olfactory bulb of anesthe-
tized, freely breathing rats (Rubin and Katz, 1999;
Neuron
336Uchida et al., 2000; Meister and Bonhoeffer, 2001). As
previously reported, presentation of odors evoked large
IOS. The odor-induced change in reflected light intensity
(DR/R) often exceeded 1% and the signal-to-noise ratio
was sufficient to resolve responses in single trials
(Figure 1A). The raw odor-evoked DR/R signal could
be decomposed into three components with different
spatial characteristics. The first component (not shown)
was a large-amplitude, low-frequency oscillation pres-
ent in the absence of sensory stimuli (Meister and Bon-
hoeffer, 2001). The frequency range of this signal (0.1 to
0.15 Hz) matched descriptions of a vasomotion signal
previously observed throughout the brain (Mayhew
et al., 1996; Kleinfeld et al., 1998). Because this stimu-
lus-independent component was spatially uniform, it
was effectively removed by subtracting the spatial aver-
age over the entire image at each time point (see Exper-
imental Procedures).
The remaining signals were time-locked to stimulus
onset and showed odor-specific spatial patterns of in-
creased absorption (darkening) (Rubin and Katz, 1999)
(Figure 1B). These odor-induced IOS could be further
separated by spatial filtering into low (DR/Rlp) and high
(DR/Rhp) spatial frequency components, both of which
remained time-locked to odor onset and showed odor-
specific spatial distributions. High-pass filtered images
(200 mm Gaussian smoothing kernel) showed a charac-
teristic pattern of punctate spots approximately 50–
150 mm in diameter, the pattern of which changed with
odor identity.
By applying pharmacological agents concomitantly
with optical imaging, we sought to dissect the pathway
from neural activity to IOS. The amplitude of IOS evoked
by the odor phenol (0.2%–0.4% of saturated vapor) was
used to quantify drug effects because it evoked a re-
stricted set of particularly discrete and bilaterally sym-
metric glomerular IOS. Drug effects were confirmed us-
ing structurally dissimilar odors (caproic acid and
acetophenone) that evoked activity in other regions of
the bulb.
We first used tetrodotoxin (TTX) to determine the
components of the IOS that were dependent on neural
activity. Direct injection of TTX (20–100mM) through a mi-
cropipette produced a rapid local inhibition of both the
punctate and the diffuse odor-evoked components of
the IOS (n = 4). In contrast, TTX did not affect the slow
oscillatory component (not shown). This result indicates
that, as expected, the odor-evoked components of the
IOS are indeed dependent on local neural activity in
the form of action potentials. On the other hand, the pu-
tative vasomotion signal is not dependent on local spik-
ing activity. Signals obtained using high-pass spatial fil-
tering have been previously shown to have a high spatial
correlation with histologically-defined glomeruli (Mei-
ster and Bonhoeffer, 2001). In the following experiments,
unless otherwise noted, we based our measurements of
IOS amplitude on the punctate component (high-pass
filtered, DR/Rhp signal).
Although the pressure injection method was effective,
in order to minimize trauma to the preparation, we used
topical application of pharmacological agents in Gel-
foam to the surface of the bulb (see Experimental Proce-
dures). We used TTX to estimate the effective dilution of
drugs produced by this method. In olfactory bulb slicepreparations, TTX is effective at around 0.3 mM (Aronia-
dou-Anderjaska et al., 1999; Schoppa and Westbrook,
2001). Application of 1 mM TTX using Gelfoam was
Figure 1. Description of Odor-Evoked IOS in the Olfactory Bulb
(A) Imaging protocol. IOS are recorded in a series of individual trials
of 20 s duration. Diagram shows the timing of baseline (R0) and re-
sponse (R1) images and the odor stimulus (black bar). Frames
were acquired at 30 frames/s and R0 and R1 were calculated by av-
eraging all frames in the time periods indicated.
(B) From left to right: The dorsal olfactory bulb illuminated at 540 nm.
Raw DR/R image (average of five trials) at 630 nm evoked by phenol
(0.2% of saturated vapor). Low-pass filtered image (DR/Rlp; Gauss-
ian kernel of s = 200 mm). High-pass filtered image (DR/Rhp). Note
that the mean image value has been subtracted from both low-
pass and high-pass filtered images. See Experimental Procedures
for description of the decomposition of the raw image into compo-
nents. In all images both left and right bulbs are shown and the an-
tero-posterior axis is from left to right. Scale bar in the leftmost im-
age shows 1 mm. The DR/R activity scale is shown in (C).
(C and D) Activity dependence of odor-evoked IOS components. A
smaller region of one hemi-bulb is shown for the same image com-
ponents as described in (B) (i.e., all images in a column were calcu-
lated in the same manner). The orientation and DR/R scale are the
same as in (B). The spatial scale bar is 200 mm. (C) Control DR/R im-
ages in response to phenol. (D) DR/R images in response to phenol,
taken after application of TTX (30 mM). The white dotted circle indi-
cates a region of interest placed over the region responding to phe-
nol. DR/R (raw, low-pass, or high-pass) from the region of interest
was averaged and plotted at a resolution of 1 s to produce the
time courses shown below each corresponding image. Note that
the mean image value at each time point has been subtracted
from both low-pass and high-pass filtered signals. Black bars on
the time course graphs show the period of odor presentation. The
thin horizontal line represents DR/R = 0.
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337without effect (96%6 12% of control, n = 2), presumably
due to the continual turnover of cerebrospinal fluid. A
30-fold higher concentration of TTX (30 mM), produced
a nearly complete block of both punctate and diffuse
odor-evoked signals (respectively, 5% 6 4% and 15%
6 8% of control; n = 2) (Figures 1C and 1D). From these
data we estimated that in our experimental conditions
the effective dilution was a factor of 50–100 compared
to in vitro conditions. For further experiments we applied
drugs at 500–1000 times the in vitro dosage in order to
ensure effective concentrations were reached.
Presynaptic Regulation
Are IOS directly coupled to action potentials of afferent
olfactory receptor neurons (ORNs) or do they require
neurotransmitter release? In vitro studies show that DA
D2 agonists (Coronas et al., 1997; Duchamp-Viret
et al., 1997) and GABA-B agonists (Bonino et al., 1999;
Koster et al., 1999; Duchamp-Viret et al., 2000) are capa-
ble of inhibiting electrically-evoked synaptic transmis-
sion from ORNs to M/TCs without affecting input action
potentials (Nickell et al., 1994; Hsia et al., 1999; Wacho-
wiak and Cohen, 1999; Aroniadou-Anderjaska et al.,
2000; Berkowicz and Trombley, 2000; Ennis et al., 2001;
Palouzier-Paulignan et al., 2002). These drugs mimic
the action of DA and GABA release from JGCs by activat-
ing D2 and GABA-B receptors located on ORN terminals
(McLean and Shipley, 1988; Coronas et al., 1997; Duch-
amp-Viret et al., 1997, 2000; Bonino et al., 1999; Koster
et al., 1999; Gutierrez-Mecinas et al., 2005) and suppress-
ing presynaptic Ca2+ influx and glutamate release (Hsia
et al., 1999; Ennis et al., 2001; Wachowiak et al., 2005).
Therefore, if IOS require neurotransmitter release, they
should be sensitive to D2 and GABA-B agonists (see
Figure 5 for a schematic representation of the glomerular
network).
Coapplication of DA and GABA-B agonists (50 mM
apomorphine and 10 mM baclofen) dramatically de-
creased odor-evoked IOS (Figure 2). In order to insure
that possible rundown of IOS (Meister and Bonhoeffer,
2001) was not mistaken for agonist effects, we imaged
left and right bulbs simultaneously and infused one
bulb with drugs while the other bulb served as a control.
DA and GABA-B agonist application reduced the signal
in the treated bulb, while the signal in the control bulb
was unaffected (Figures 2A and 2B). Figure 2C shows
the trial-by-trial amplitude of odor-evoked responses
over the course of this experiment. To obtain a popula-
tion measurement, time courses from individual experi-
ments were normalized to their average baseline ampli-
tude and then averaged (Figure 2D). In the experiment
shown in Figure 2C, both treated and control hemi-bulbs
were stable throughout the baseline and treatment
periods, but sometimes a small amount of rundown
was seen. To control for this, reported drug effects
(Figure 2E) were cross-normalized (i.e., the average nor-
malized amplitude of the treated hemi-bulb was divided
by the average normalized amplitude of the control
hemi-bulb) (see Experimental Procedures).
In order to determine the relative contributions and
possible interaction of DA and GABA-B receptors (Gall
et al., 1987), we examined the effects of DA and
GABA-B agonists separately. Apomorphine (50 mM)
caused a significant reduction in IOS (70% 6 12% ofcontrol, p < 0.05, n = 3; Figure 2E), as did baclofen
(10 mM) (66%6 6% of control, p < 0.05, n = 3; Figure 2E).
The combined DA and GABA-B agonists (50 mM apo-
morphine and 10 mM baclofen) produced a net (cross-
normalized) reduction of the signal to 25% 6 12% of
control (p < 0.001, n = 4; Figure 2E). The effectiveness
of this combination in suppressing IOS (block almost
equal to TTX) indicates that presynaptic action poten-
tials are ineffective in generating IOS, unless they are
coupled through some signaling pathway downstream
of Ca2+ entry and transmitter release. The effect of the
coapplied agonists was slightly greater than linear sum-
mation (75% block coapplied versus 30% + 34% = 64%
block for the sum of individual effects). This result is
consistent with the idea that DA and GABA systems
act on distinct targets and indicates that both are effec-
tive in regulating glomerular metabolic activity as well
as neural activity (Sallaz and Jourdan, 1992; Keller
et al., 1998).
These experiments with exogenous agonists estab-
lish the potential capacity of DA and GABA-B receptors
to suppress odor-evoked IOS, but does natural odor
stimulation itself recruit such feedback inhibition? In vi-
tro studies have found that GABA-B antagonists in-
creased M/TCs activity evoked by electrical olfactory
nerve stimulation (Aroniadou-Anderjaska et al., 2000).
In vivo, imaging studies have recently shown an in-
crease in odor-evoked presynaptic Ca2+ signals in the
presence of GABA-B antagonists (Wachowiak et al.,
2005; Vucinic et al., 2006). Block of GABA-B receptors
by the specific GABA-B receptor antagonist 2S-(+)-5,5-
dimethyl-2-morpholineacetic acid (SCH-50911) caused
an increase in IOS (121% 6 12% of control, p < 0.05;
n = 4). The strength of enhancement by GABA-B block-
ade was substantial relative to the reduction by baclofen
injection (21% increase versus 34% decrease). This ob-
servation shows that sensory-evoked IOS are indeed
modulated by endogenous as well as exogenous
GABA-B receptor activation.
Postsynaptic Receptors
How is presynaptic activity linked to the generation of
IOS? Postsynaptic ionotropic glutamate receptors (a-
amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
[AMPA] and N-methyl-D-aspartic acid [NMDA] recep-
tors) are the major targets of glutamate released in
glomeruli (Berkowicz et al., 1994; Ennis et al., 1996; Aro-
niadou-Anderjaska et al., 1997). Activation of these re-
ceptors creates postsynaptic potentials and action po-
tentials in M/TCs and JGCs. Such postsynaptic activity
has been proposed to be the major energy sink in the
brain (Attwell and Laughlin, 2001) and has been sug-
gested to underlie the generation of IOS (Bonhoeffer
and Grinvald, 1996).
To test the contribution of postsynaptic sources to
IOS, we applied a mixture of glutamate receptor antag-
onists—the NMDA receptor antagonist DL-2-amino-5-
phosphonopentanoic acid (DL-APV) (50 mM) and the
AMPA receptor antagonist 2,3-dioxo-6-nitro-1,2,3,4-
tetrahydrobenzoquinoxaline-7-sulfonamide (NBQX) (5
mM). Surprisingly, this treatment caused no decrease
in the IOS. An individual experiment is shown in Figures
3A–3C, and population data are shown in Figure 3D. The
net effect of these antagonists was a small but
Neuron
338Figure 2. DA and GABA-B Receptor Agonists Block IOS
(A and B) An individual experiment showing the effect of a combina-
tion of DA and GABA-B agonists (apomorphine, 50 mM, and baclo-
fen, 10 mM). The time course of the phenol-evoked IOS (high-pass
filtered, DR/Rhp) is shown for the control hemi-bulb (A) and the
drug-treated hemi-bulb (B). Dashed line, baseline condition; solid
line, same region after application of drug. Each trace is the average
of three trials. Black bar indicates the period of odor presentation.
IOS time courses were calculated using bilaterally symmetric regions
of interest as described in Figure 1 and the Experimental Procedures.
(C) Trial-by-trial amplitude of IOS (DR/Rhp) from the same experiment
shown in (A)and (B).Graysymbols,control hemi-bulb; blacksymbols,
treated hemi-bulb. Amplitudes were averaged over the time windows
shown in Figure 1A. Arrow indicates the time of drug application.
(D) Population data showing average trial-by-trial amplitude of IOS for
experiments like that depicted in (A–C) in which DA and GABA-B ag-
onists were coapplied. The data were self-normalized by dividing by
the average of baseline trials. Gray symbols, control hemi-bulb; black
symbols, treated hemi-bulb. Each data point is the mean6SEM (n = 4
animals).
(E) Summary of different experiments with DA and GABA-B agonists
and antagonists. The value of the self-normalized amplitude in the
treated hemi-bulb after drug application (averaged over 4–6 trials)
was divided by the self-normalized amplitude in the corresponding
control hemi-bulb over the same period. Bar graph shows, from left
to right, DA and GABA-B agonists together (apomorphine, 50 mM,
and baclofen, 10 mM, n = 4), DA agonist alone (apomorphine, 50
mM, n = 3), GABA-B agonist (baclofen, 10 mM, n = 3), and GABA-B an-
tagonist (SCH-50911, 100 mM, n = 4). Error bars represent SEM
across animals. Significance was calculated using a paired t test
comparing self-normalized values of control and treated sides for
each drug treatment (*p < 0.05; ***p < 0.001).significant enhancement of the punctate glomerular sig-
nal (120%6 4% of control, p < 0.01, n = 7; see Figure S1
in the Supplemental Data). This finding indicates that
postsynaptic activation through fast synaptic signaling
and consequent postsynaptic depolarization are not
necessary for generation of odor-evoked IOS. A likely
explanation for the increase in the odor-evoked signal
is a blockade of AMPA/NMDA receptors on juxtaglomer-
ular cells that normally provide feedback inhibition
through GABA-B receptors (Wachowiak et al., 2005;
McGann et al., 2005; Vucinic et al., 2006). The similar
magnitudes of increase observed with the GABA-B an-
tagonist SCH-50911 and NBQX/DL-APV suggest that
blockade of presynaptic inhibition can fully account for
the NBQX/DL-APV effect, but also that relief of inhibition
is not large enough to mask a suppressive effect of
NBQX/DL-APV. Interestingly, the odor-specific diffuse
signal was typically enhanced to a greater extent than
the punctate signal (139% 6 17% of control, p < 0.05,
n = 7; Figure S1), consistent with a role for juxtaglomer-
ular cells in interglomerular lateral inhibition (Vucinic
et al., 2006).
To further establish that glutamate receptor antago-
nists were sufficient to block postsynaptic ionotropic
glutamate responses, we tested the effect of DL-APV
and NBQX on glomerular local field potentials (LFPs).
Odor-evoked LFPs were oscillatory, variable in ampli-
tude, and outlasted stimulation by many seconds.
Therefore, we used electrical stimulation of the olfactory
nerve to assay the effectiveness of glutamate antago-
nists. Electrically evoked LFPs recorded in the glomeru-
lar layer had temporal profiles similar to those previously
described, acquired using olfactory nerve stimulation in
slices (Aroniadou-Anderjaska et al., 1997), with an initial
large negative deflection with a peak latency of 8.63 6
0.13 ms (n = 4, Figure 3E). Application of NBQX
(5 mM) + DL-APV (50 mM) topically to the bulb reduced
LFP amplitude to 11% of control (21.2 6 0.2 mV base-
line,20.136 0.03 mV in the presence of the antagonists,
p < 0.05; n = 3). LFPs were stable under similar condi-
tions in the absence of antagonists. We therefore con-
clude that glutamate receptor antagonists reach con-
centrations sufficient to block excitatory synaptic
transmission and that activation of postsynaptic gluta-
mate receptors is not required to generate odor-evoked
IOS.
These experiments argue against a dependence of
IOS on postsynaptic ionotropic glutamate receptors,
but do not exclude the possibility of a metabotropic glu-
tamate receptor (mGluR)-mediated pathway. Indeed,
mGluR1 has been implicated in postsynaptic M/TC re-
sponses in vitro (Schoppa and Westbrook, 2001; Hein-
bockel et al., 2004; De Saint Jan and Westbrook, 2005;
Yuan and Knopfel, 2006; Ennis et al., 2006). We checked
for the involvement of mGluRs using the broad-spec-
trum group I/II antagonist (S)-a-methyl-4-carboxyphe-
nylglycine (MCPG) (50 mM) and the more specific
mGluR1 antagonist LY367385 (15 mM). Neither drug
had an effect on the amplitude of odor-evoked IOS
(MCPG: 99% 6 17% of control, n = 2, not shown;
LY367385: 104% 6 9%, p > 0.05, n = 5, Figure 4E).
Thus, neither ionotropic nor metabotropic postsynaptic
glutamate receptors appear to mediate the coupling of
neural activity to IOS.
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If IOS are downstream of presynaptic ORN activity, but
independent of postsynaptic glutamate receptor activa-
tion, how is neural activity coupled to IOS? In addition to
presynaptic and postsynaptic neuronal components,
astrocytes are another arm of the synaptic signaling
triad (Araque et al., 2001). Astrocytes are recognized
as the central mediator of a host of critical metabolic
and hemodynamic processes (Bonvento et al., 2002;
Nedergaard et al., 2003). Glomeruli express low levels
of neuronal glutamate transporters, but very high levels
of the astrocytic glutamate transporters GLAST and
Figure 3. Glutamate Receptor Antagonists Fail to Block Odor-
Evoked IOS
(A–D) The effect of glutamate receptor (AMPA and NMDA) antago-
nists (NBQX, 5 mM, and DL-APV, 50 mM) on the IOS. (A–C) Single ex-
periment. (D) Population data (n = 4 animals). Calculations and sym-
bols in (A–D) are as described in Figures 2A–2D.
(E) Bar graph shows LFP amplitude recorded in the glomerular layer
in response to electrical ON-stimulation in vivo in control conditions
and during application of NBQX and DL-APV (mean6 SEM, n = 3 an-
imals). Inset shows average LFP traces from one experiment. Dotted
trace, baseline condition, average of ten responses. Solid trace,
application of NBQX (5 mM) + DL-APV (50 mM), average of 20
responses. Horizontal bar, 0.4 mV; vertical bar, 5 ms. The stimulus
artifact (black dot) has been truncated.GLT1, with GLAST dominating the core of the glomeru-
lus and GLT1 dominating the surrounding shell (Utsumi
et al., 2001). Both astrocytic transporters are responsi-
ble for glutamate clearance in olfactory glomeruli (De
Saint Jan and Westbrook, 2005). In addition, glutamate
uptake by astrocytes has been linked to the generation
of IOS in vitro (Schneider et al., 1992; Buchheim et al.,
2005). Could neural activity be linked to glomerular IOS
through astrocytic glutamate uptake?
To test the role of astrocytic glutamate uptake in the
generation of sensory-evoked IOS, we applied DL-
threo-b-benzyloxyaspartate (TBOA), a very effective
blocker of both GLAST and GLT1 (Figure 4) (De Saint
Figure 4. Glutamate Uptake Blocker TBOA Blocks IOS
(A–D) The effect of TBOA (10 mM), a blocker of the glutamate trans-
porters GLT1 and GLAST, on the IOS. (A–C) Single experiment. (D)
Population data (n = 5 animals). Calculations and symbols in (A–D)
are as described for Figures 2A–2D.
(E) Summary of experiments with the glutamate transporter blocker
TBOA and the metabotropic glutamate receptor antagonist
LY367385. Bar graph shows, from left to right, effects of TBOA alone
(n = 5), LY367385 alone (n = 5), and TBOA and LY367385 together (n =
4). Calculations are as describe for Figure 2E. (Statistical signifi-
cance: NS, not significant, p > 0.05; **p < 0.01).
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lus and Origins of Functional Optical Signals
Diagram illustrating the circuitry of the olfac-
tory bulb glomerulus and proposed mecha-
nisms underlying the generation of odor-
evoked IOS. Glutamate released by sensory
activation of ORNs acts via three pathways:
(1) Juxtaglomerular cells, sensing glutamate
by ionotropic receptors (AMPA and NMDA),
provide inhibitory feedback control of release
through dopamine (DA) and GABA acting on
presynaptic receptors. (2) Astrocytes, acti-
vated by glutamate transporters (GLT1,
GLAST), produce changes in light scattering
(due to cell swelling) and blood flow, resulting
in intrinsic optical signals (IOS). (3) Postsyn-
aptic neurons, activated by metabotropic
and ionotropic glutamate receptors, transmit
electrical signals downstream but are inde-
pendent of the generation of IOS.Jan and Westbrook, 2005). Application of TBOA (10 mM)
strongly inhibited odor-evoked IOS (Figures 4A and 4B).
The time course of an individual experiment is shown in
Figure 4C, and population data is shown in Figure 4D.
The net (cross-normalized) amplitude of IOS in TBOA
was reduced by about two-thirds (36%6 6% of control,
p < 0.005; n = 5).
The dependence of IOS on TBOA suggests that acti-
vation of astrocytic glutamate transporters could be
a critical step in the pathway linking the sensory-evoked
neuronal activity to IOS in the olfactory bulb. However,
blockade of uptake enhances the concentration of glu-
tamate in the glomerulus, which could recruit mGluR
responses. TBOA (10 mM) applied topically to the olfac-
tory bulb surface had a variable effect on electrically-
evoked LFPs (39% 6 20% of control, p > 0.05; n = 3).
TBOA is known to enhance mGluR1-mediated re-
sponses in M/TCs (De Saint Jan and Westbrook, 2005;
Ennis et al., 2006; Yuan and Knopfel, 2006). In order to
test whether TBOA acts by enhancing mGluR1 activity,
we coapplied the mGluR1 antagonist LY367385 with
TBOA. The block of IOS in the presence of the
LY367385 was similar compared to TBOA alone (42% 6
6%, n = 4, p < 0.01; Figure 4E). Thus, we conclude that
mGluR1 signaling does not mediate the inhibitory
effects of TBOA.
Discussion
We used local pharmacology during in vivo imaging and
electrophysiology to dissect the link between sensory-
evoked neural activity and functional imaging signals.
We found that odor-evoked IOS in the olfactory bulb
are downstream of presynaptic glutamate release but
do not depend on postsynaptic activity through either
ionotropic or metabotropic glutamate receptors. IOS
were blocked by an inhibitor of astrocytic glutamate up-
take. Thus, glutamate release could be coupled to IOS
directly through the activation of astrocytic glutamate
transporters, although we did not rule out a contribution
from other pathways. A schematic summarizing theinferred pathways is shown in Figure 5. Together, our
data are consistent with the view that astrocytes play
a critical role in coupling metabolic and vascular re-
sponses to neural activity and are hence essential to
the genesis of functional imaging signals.
Coupling of IOS to Presynaptic, but Not
Postsynaptic, Activity
We focused our analysis on a component of IOS that
was time-locked to odor presentation and showed
odor-specific patterns of punctate spots (Rubin and
Katz 1999; Uchida et al., 2000; Wachowiak and Cohen,
2003; Uchida and Mainen 2003) previously shown to
be correlated with anatomical markers of glomeruli (Mei-
ster and Bonhoeffer, 2001). Odor-specific IOS were
completely blocked by TTX, demonstrating that they de-
pend on action potentials. In addition, we found large
IOS in the olfactory bulb in the form of an ongoing oscil-
latory (approximately 0.1 Hz) signal that was neither spa-
tially nor temporally related to odor stimulation, nor sen-
sitive to application of TTX. The frequency of this
component suggests a correspondence with a previ-
ously described vasomotion signal (Mayhew et al.,
1996; Kleinfeld et al., 1998) as opposed to an artifact of
respiration (0.5–2 Hz) or heartbeat (3–8 Hz).
Sensory-evoked IOS were strongly inhibited by
GABA-B and DA agonists. In vitro studies have shown
that the same agonists are capable of suppressing syn-
aptic potentials evoked by electrical stimulation of the
olfactory nerve (Keller et al., 1998; Hsia et al., 1999; Aro-
niadou-Anderjaska et al., 2000; Ennis et al., 2001). Our
results show that DA and GABA-B receptors are capable
individually of suppressing odor-evoked sensory activ-
ity and resultant IOS. The additive effects of these two
receptor systems were roughly linear, so that together
they were capable of dramatically reducing the meta-
bolic responses of the olfactory bulb to sensory stimula-
tion. In addition to this, we also showed that blockade of
GABA-B receptors increased odor-evoked IOS. To our
knowledge, our data, together with reports from Wacho-
wiak et al. (2005) and Vucinic et al. (2006), are some of
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vated by normal sensory-evoked activity in the olfactory
bulb and that these receptors serve to limit transmission
of sensory signals. We believe GABA-B and DA agonists
to be acting presynaptically on ORN terminals because
glomeruli express D2 and GABA-B receptors presynap-
tically (McLean and Shipley, 1988; Coronas et al., 1997;
Duchamp-Viret et al., 1997; Bonino et al., 1999; Koster
et al., 1999; Gutierrez-Mecinas et al., 2005). It remains
possible that the small component that was not sup-
pressed by these agonists reflects a release-indepen-
dent component of the IOS (e.g., one due to some other
mechanism of coupling of presynaptic action poten-
tials). However, the data suggest that presynaptic action
potentials are necessary, but not sufficient, to generate
IOS.
Why is there a need for powerful and redundant feed-
back inhibition in the olfactory glomerulus? The high
convergence ratio of ORNs to glomeruli (>5000:1, Mom-
baerts, 1999) and high probability of release from ORN
terminals (pz 1; Murphy et al., 2004) imply that the glo-
merulus serves to amplify receptor signals by pooling in-
put from many individual receptor neurons, perhaps fa-
cilitating odor detection. If a single mitral cell could be
activated by a single receptor neuron at threshold
odor concentrations, then higher concentrations of
odorants would overwhelm the postsynaptic neurons
well before saturating the olfactory receptors. Multiple
presynaptic inhibitory feedback mechanisms could
compress the dynamic range of the pooled sensory neu-
ron input to that of M/TCs. The presence of astrocytes
(Bailey and Shipley, 1993; Chao et al., 1997) containing
glycogen (Coopersmith and Leon, 1995), intense glu-
cose consumption (Johnson and Leon, 2000), and
a dense capillary network (Chaigneau et al., 2003) are
all signs of the high metabolic demands on processing
in olfactory glomeruli. Our results demonstrate that pre-
synaptic inhibition by GABA-B and DA receptors not
only suppresses afferent neural activity (Nickell et al.,
1994; Hsia et al., 1999; Wachowiak and Cohen, 1999; Ar-
oniadou-Anderjaska et al., 2000; Berkowicz and Tromb-
ley, 2000; Ennis et al., 2001; Palouzier-Paulignan et al.,
2002), but that GABA-B and DA receptors are highly ef-
fective in limiting the consumption of energy in the olfac-
tory bulb (Sallaz and Jourdan, 1992). Presynaptic inhibi-
tion is likely to be critical in governing the interplay
between maximization of information transmission and
minimization of energy consumption.
Odor-evoked IOS were not blocked by antagonists of
postsynaptic AMPA- and NMDA-type glutamate recep-
tors (NBQX and DL-APV, respectively), while the same
antagonists blocked electrically evoked LFPs. Thus,
our data demonstrate that the generation of IOS does
not depend on conventional synaptic transmission to
activate postsynaptic electrical responses. Surprisingly,
these antagonists actually increased odor-evoked IOS.
One possible mechanism to explain this increase is the
blockade of presynaptic inhibition mediated by JGCs
(notably GABAergic JGCs) activated by glutamate re-
leased from ORN input terminals (Wachowiak et al.,
2005; McGann et al., 2005; Vucinic et al., 2006). Consis-
tent with this idea, the fractional increase in NBQX+APV
was comparable to that produced by the GABA-B
blocker SCH-50911 (around 20%).The remaining glutamatergic pathway to the postsyn-
aptic cell is through mGluR (van den Pol, 1995). mGluR1
agonists depolarize MCs (Schoppa and Westbrook,
1997) and induce Ca2+ transients in the apical dendrites
of MCs (Yuan and Knopfel, 2006). However, the broad-
spectrum group I/II mGluR antagonist MCPG and the
specific mGluR1 antagonist LY367385 had no affect on
odor-evoked signals. Thus, glomerular IOS do not ap-
pear to require any form of glutamatergic activation of
M/TCs.
The lack of involvement of postsynaptic neurons in
the generation of the IOS is counterintuitive insofar as
postsynaptic signaling has been estimated to be the
dominant cost term in the brain’s energy budget (Attwell
and Laughlin, 2001). However, our finding is consistent
with conclusions from a study using two-photon imag-
ing of blood flow in glomerular capillaries that showed
that odor-evoked blood flow is not inhibited by gluta-
mate receptor antagonists (E. Chaigneau, J. Lecoq,
and S. Charpak, 2005, Soc. Neurosci. abstracts). Thus,
both sensory-evoked IOS and blood flow appear to be
independent of postsynaptic activation in olfactory glo-
meruli. Our findings are also in line with studies showing
that odor-evoked IOS are well-correlated with presyn-
aptic Ca2+ signals measured in ORN terminals (Wacho-
wiak and Cohen, 2003).
The contribution of presynaptic versus postsynaptic
activity to blood flow has been investigated in two other
systems. The blood oxygenation level-dependent func-
tional magnetic resonance imaging (BOLD-fMRI) signal
in primary visual cortex of monkeys is better correlated
with input and local activity than output (spiking) activity
(Logothetis et al., 2001; Kayser et al., 2004), and stimu-
lus-evoked changes in cerebral blood flow in the cere-
bellum depend on excitatory input but are independent
of postsynaptic firing (Mathiesen et al., 1998; Caesar
et al., 2003; Thomsen et al., 2004). Here we provide
even more direct evidence that cutting off the postsyn-
aptic electrical signaling pathway with glutamate antag-
onists does not interfere with the generation of sensory-
evoked IOS.
Coupling Neural Activity to IOS through Astrocytic
Glutamate Uptake
If IOS are not coupled to glutamate release through de-
tection by postsynaptic neurons, then how is the gluta-
mate signal transduced? Astrocytes are known to be
central to numerous aspects of metabolic and synaptic
signaling, including glutamate recycling and uptake and
glucose metabolism, which are tightly linked (Pellerin
and Magistretti, 1994; Cholet et al., 2001; Sibson et al.,
1998; Voutsinos-Porche et al., 2003). Astrocytes are
also key players in other metabolic processes such as
extracellular potassium clearance (MacVicar and Hoch-
man, 1991; MacVicar et al., 2002; Higashi et al., 2001; De
Saint Jan and Westbrook, 2005), regulation of blood flow
(Simard et al., 2003; Zonta et al., 2003; Mulligan and
MacVicar, 2004; Takano et al., 2005), and shuttling of
lactate to neurons (Pellerin and Magistretti, 1994; Bouz-
ier-Sore et al., 2003). Astrocytic metabolic processing
appears to be coupled to neural activity through multiple
signaling pathways much as neurons are coupled to one
another by multiple transmitters and receptors.
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GLT1 blocker TBOA. This effect is consistent with the
possibility that these astrocytic glutamate transporters
themselves mediate the linkage between electrical and
metabolic signals. However, TBOA also blocked, with
variable efficacy, electrically recorded glomerular
LFPs, an effect that could reflect a reduction of release
by presynaptic mGluR activated by excess glutamate
arising from blockade of transporters, as reported at
some central synapses (Iserhot et al., 2004). Thus, we
did not rule out the possibility that TBOA reduced
odor-evoked IOS in part by reducing presynaptic re-
lease. Nevertheless, previous observations in olfactory
glomeruli argue against this possibility. First, in vitro
studies show that TBOA increases rather than de-
creases mitral cell activity (De Saint Jan and Westbrook,
2005). Second, TBOA has a relatively small effect on pre-
synaptic ORN signals (McGann et al., 2005). Thus, it
seems unlikely that the >60% block of IOS by TBOA
can be explained by an indirect effect of presynaptic in-
hibition of transmitter release. Since postsynaptic neu-
ronal responses were not required for generation of
IOS, an astrocyte-mediated pathway is implied. Al-
though the most obvious route is through the trans-
porter itself, TBOA might also act indirectly by interfer-
ing with a glutamate sensor on astrocytes. Group I
mGluR would be a chief candidate (e.g., Zonta et al.,
2003; Wang et al., 2006), but the mGluR antagonist
LY367385 did not alter the effect of TBOA when
coapplied.
How Astrocytes Produce IOS
How could astrocyte activation lead to IOS? IOS are be-
lieved to arise from changes in three factors: light scat-
tering, blood oxygenation level, and blood volume
(Bonhoeffer and Grinvald, 1996). Previous work in the
olfactory bulb suggested that glomerular IOS have
a broad spectral profile consistent with light scattering
(Meister and Bonhoeffer, 2001). In vitro studies have
provided insight into how light-scattering changes are
generated (Aitken et al., 1999). Glutamate uptake by
GLT1 and GLAST relies on the electrochemical gradient
of Na+ ions as a driving force (Danbolt, 2001). The resto-
ration of these gradients induces changes in osmolarity
(MacAulay et al., 2004), causing cell swelling and a de-
crease in extracellular volume fraction that produces
light-scattering changes (Fayuk et al., 2002). The rela-
tively slow recovery of the IOS (tens of seconds) is con-
sistent with the slow time scales of recovery from swell-
ing (MacVicar et al., 2002) and astrocytic metabolic
processing (Kasischke et al., 2004).
Direct measurements of capillary blood flow show
that, in addition to the light-scattering change, sensory
activity evokes a hemodynamic response in olfactory
glomeruli (Chaigneau et al., 2003). These distinct sour-
ces reflect different aspects of metabolism and blood
flow and, as discussed above, different signaling path-
ways. Group I mGluR (gluR1/5) activation is a pathway
linking neuronal activity to the control of blood flow by
astrocytes (Zonta et al., 2003), but blocking these mGluR
had no affect on odor-evoked IOS. Therefore, either the
contribution of blood flow signals to the IOS is minimal in
our experiments, or else hemodynamic responses arise
from a non-mGluR pathway in the olfactory glomeruli.The interplay between oxidative and nonoxidative me-
tabolism (Fox and Raichle, 1986; Kasischke et al.,
2004) will likely be a central determinant of the relative
contributions of different metabolic signals to IOS.
These contributions may depend on factors such as
the type of neural tissue and the metabolic state of the
animal (e.g., depth of anesthesia). The olfactory glomer-
ulus is well-suited to further studies aimed at unraveling
these relationships.
Metabolic Computation
In conclusion, the present data provide a novel view on
the mechanisms entangling electrical and metabolic ac-
tivity—information and energy—in the nervous system.
It is increasingly recognized that energy consumption
is a key constraint on neural function that must be con-
sidered alongside computational objectives (Attwell and
Laughlin, 2001; Laughlin and Sejnowski, 2003). Our re-
sults demonstrate that functional metabolic signaling
does not follow postsynaptic activation and energy con-
sumption, but rather suggest a parallel arrangement that
is likely to involve the direct activation of astrocytes by
presynaptic glutamate release. This feedforward signal-
ing pathway would place astrocytes in the role of not
only responding to, but also predicting, energy de-
mands of the postsynaptic neurons. Such an arrange-
ment may seem overly complex, but it reflects the fact
that energy supply and demand are not passively cou-
pled: between the energy consumers (ion pumps, gluta-
mate recycling, etc.) and the ultimate energy supply
(glucose, oxygen) is an intricate metabolic network
(Magistretti et al., 1999; Attwell and Iadecola, 2002;
Raichle and Mintun, 2006). Astrocytes are clearly at the
center of the complex problem of energy budgeting
and calculation (Pellerin and Magistretti, 2004), and
only by communicating rapidly and efficiently with neu-
rons can they perform these functions. By detecting lo-
cal glutamate release, astrocytes can not only perform
direct support functions—recycling transmitter and
maintaining ionic gradients—but also sense and partic-
ipate in the metabolic computations of local circuits.
Experimental Procedures
Long Evans rats (200–300 g) were deeply anesthetized using medeto-
midine and fentanyl (0.05 and 0.01 mg/kg, i.p.) and placed in a stereo-
taxic frame. A local anesthetic (lidocaine) was applied topically dur-
ing surgery. Anesthesia was maintained by periodic dosage with
medetomidine (w0.25 mg/kg/hr). The bone over the dorsal surface
of both olfactory bulbs was thinned using a dental drill and the
bone and dura were carefully removed. Two small wells were con-
structed using dental cement around each hemi bulb. The wells
were filled with agarose (2%) and covered with a glass coverslip to
limit movements due to breathing. Body temperature was maintained
at 37C using a heating blanket throughout the experiment. Free
breathing rate (w2 Hz) and partial oxygen pressure were monitored.
Data acquisition and analysis were performed using custom soft-
ware (Z.F.M.) written in MATLAB (MathWorks, Natick, MA). Glomer-
ular intrinsic signals were measured by the detection of red light re-
flectance using an analog CCD camera (Teli, Tokyo, Japan) mounted
on a stereomicroscope (Olympus SZ40). Images were acquired at
30 Hz using a 10 bit frame grabber board (Matrox Pulsar, Dorval,
Canada), temporally binned to 2 Hz, and saved to disk. The brain
surface was illuminated using LEDs at 540 nm (for focusing
150 mm below pial surface) and LEDs at 630 or 660 nm (for imaging).
Light reflectance values were collected over a 3 3 4 mm area
(10 mm/pixel). Each imaging trial lasted 20 s, consisting of 5 s of
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343baseline, 10 s of odor presentation, and 5 s following stimulus termi-
nation (Figure 1A). Odors were delivered using a custom-designed,
computer-controlled olfactometer (Uchida and Mainen, 2003) at in-
tervals of 60 s.
IOS were quantified by calculating the relative change in reflec-
tance, DR/R = (R1 – R0)/R0, where R0 is the temporal average of im-
ages acquired 5 to 0 s before odor onset and R1 is the average of im-
ages acquired 5 to 15 s after odor onset (Figure 1A). The DR/R
images were separated into three components: the spatial average
pixel value, DR/Ravg; a low-pass filtered image, DR/Rlp; and a high-
pass filtered image, DR/Rhp (Figure 1B). To produce this decompo-
sition, first DR/Ravg was calculated as the mean pixel value for each
frame. By definition, DR/Ravg is spatially uniform; we also found this
component to have a strong stimulus-independent temporal oscilla-
tion and to be TTX-independent (Figure 1). Next, DR/Rlp was calcu-
lated by convolving a Gaussian spatial kernel (s = 200 mm) with the
mean-subtracted image (DR/R – DR/Ravg). Subtracting these two
components from the raw image yielded a high-pass filtered image:
DR/Rhp = DR/R – DR/Rlp – DR/Ravg (similar to Meister and Bon-
hoeffer, 2001). To calculate the time course of IOS signals (e.g., Fig-
ures 1C–1D), the average signal value was calculated within a region
of interest (ROI) as a function of time (1 s resolution), and then DR/R
was computed for each time point.
Drugs and agarose were dissolved in artificial cerebrospinal fluid
containing, in mM, 127 NaCl, 25 NaHCO3, 25 D-glucose, 2.5 KCl,
1.0 MgCl2, 2.0 CaCl2, and 1.25 NaH2PO4. Drugs were topically ap-
plied to one hemi-bulb by temporarily removing the coverslip and
agarose. Gelfoam (Pharmacia and Upjohn, Kalamazoo, MI) contain-
ing drug-solution at 100 to 10003 slice concentration was applied
on the surface of the olfactory bulb for 20 to 30 min. TTX, (RS)-baclo-
fen, SCH-50911, DL-APV, NBQX, TBOA, MCPG, and LY367385 were
purchased from Tocris (Avonmouth, UK), and R(–)apomorphine was
purchased from Sigma-Aldrich (St. Louis, MO).
Overall experiment time was 6 to 7 hr, starting at anesthesia injec-
tion. IOS typically showed some amount of rundown during this
time, as observed previously (Meister and Bonhoeffer, 2001). In a se-
ries of parallel experiments, we measured major blood parameters
(blood gas analyzer Abl5, Radiometer Medical, Denmark) from the
peripheral circulation to estimate the impact of anesthesia on phys-
iological state over this period. Partial pressure of oxygen varied
from 93.3 6 2.3 to 82.0 6 3.1 mm Hg (n = 3), partial pressure of car-
bon dioxide from 36.0 6 2.6 to 43.3 6 4.4 mm Hg (n = 3), pH from
7.3 6 0.1 to 7.2 6 0.1 (n = 3), and blood pressure from 106.7 6 9.3
to 99.76 5.8 mm Hg (n = 3). These results suggest that metabolic ho-
meostasis is moderately affected by our anesthesia protocol and
may be the cause of the rundown of IOS.
For each experiment, baseline-normalized amplitudes were cal-
culated by dividing the average IOS amplitude (DR/Rhp unless other-
wise noted) in an ROI by the average in the same ROI during pre-
treatment baseline trials (% baseline; Figures 2D, 3D, and 4D).
Approximately symmetric ROIs were chosen for treated and control
hemi-bulbs. Experiments were rejected if rundown exceeded 30%,
but to compensate for the effect of any rundown on pharmacological
treatments, cross-normalized amplitudes were calculated by divid-
ing the baseline-normalized amplitude of the treated hemi-bulb after
drug application by the baseline-normalized amplitude of the control
hemi-bulb during the same time period (% control bulbs; Figure 2E
and Figure 4E; Figure S1E). Statistical significance was calculated
by comparing baseline-normalized control and treated bulb signals
after drug application using a paired t test.
LFPs were recorded using either a glass pipette filled with 1–2 M
NaCl (1–3 MU resistance) or a tungsten electrode (0.5 MU) lowered
into the glomerular layer. A bipolar tungsten or stainless steal stim-
ulating electrode was positioned on the surface of the olfactory bulb
anterior and lateral to the recording site. Stimulus pulses (30 to
50 mA, 100 ms duration) were delivered at 0.1 Hz. Field potentials
were recorded from a 70 to 150 mm depth and were band-pass fil-
tered from 0.1 Hz to 10 kHz. Drugs were topically applied, and the
electrical signals were acquired and analyzed using custom soft-
ware (EXPER, Z.F.M.) running under MATLAB.
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